Country: Germany
Language: English
Source: HMA (Heads of Medicines Agencies)
borrelia afzelii 1 RP, borrelia burgdorferi 1 RP, borrelia garinii 1 RP
Bioveta
QI07AB04
Suspension for injection
Borrelia
Dogs Non Food
2012-12-20
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Borrelym 3, suspension for injection for dogs (in CZ, EE, HU, LT, LV, PL, RO, SI, SK) Merilym 3, suspension for injection for dogs (in AT, BE, DE, FR, IE, IT, LU, NL, PT, UK) Trilyme, suspension for injection for dogs (in DK, FI, NO, SE) 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Composition of one dose (1 ml): ACTIVE SUBSTANCES: Inactivated_ Borrelia burgdorferi sensu lato_: _Borrelia garinii_ ............................................................ RP 1* _Borrelia afzelii ............................................................. _RP 1* _Borrelia burgdorferi sensu stricto_.................................. RP 1* *RP = Relative potency (ELISA test) compared with the reference serum obtained after vaccination of mice with a vaccine batch that has successfully passed the challenge test in the target species. ADJUVANT: Aluminium (as hydroxide).............................................. 2 mg EXCIPIENTS: Formaldehyde ............................................................... max. 0.5 mg/ml For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Suspension for injection. Pinkish up to white fluid containing white sediment that disperses easily when the content is shaken. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Dogs. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For active immunization of dogs from 12 weeks of age, to induce an anti-OspA response against _Borrelia spp. _(_B. burgdorferi sensu stricto_, _B. garinii _and _B. afzelii_). Reduction of _Borrelia_ transmission Read the complete document